<DOC>
	<DOCNO>NCT00346970</DOCNO>
	<brief_summary>The aim present study characterize novel mechanism whereby HDL may exert potent vasculoprotective effect independent reverse cholesterol transport , particular effect HDL regulation vascular NAD ( P ) H oxidase enzyme system , major vascular source superoxide , know important endothelial dysfunction . In addition , present study characterize effect HDL endothelial progenitor cell ( EPC ) mobilization , nitric oxide production vivo regenerative capacity .</brief_summary>
	<brief_title>The High Density Lipoprotein Endothelial Function , Niacin Nitric Oxide Study ( The High-Ennd Study )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Statin treatment least 3 week Reduced HDL : &lt; 40 mg/dL ( 1.03 mmol/L ) men &lt; 50 mg/dL ( 1.29 mmol/L ) woman Plus TWO follow ( thereby define patient metabolic syndrome ( Grundy et al . ; Circulation 2005 ) ) : Elevated waist circumference : ≥ 102 cm ( ≥ 40 inch ) men ≥ 88 cm ( ≥ 35 inch ) woman Elevated triglyceride : ≥ 150 mg/dL ( 1.7 mmol/L Elevated blood pressure : ≥ 130 mmHg systolic blood pressure ≥ 80 mmHg diastolic blood pressure antihypertensive treatment Elevated fast glucose : ≥ 100 mg/dL drug treatment elevate fast glucose Hypersensitivity niacin Active liver disease impair liver function Persistent elevation transaminase Cholestasis Gastric ulcer Acute coronary syndrome Gout Pregnancy , lactation Active infection Cancer Untreated concomitant disease Renal insufficiency renal failure Hypothyreosis Alcoholism Myopathies Muscle pain therapy fibrates statin Hereditary muscle disease family history</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Metabolic Syndrome</keyword>
	<keyword>High Density Lipoprotein</keyword>
	<keyword>Extended-Release Niacin</keyword>
	<keyword>Endothelial Function</keyword>
	<keyword>Endothelial Progenitor Cells</keyword>
</DOC>